PARTIAL METABOLIC CLEARANCES AS DETERMINANTS OF THE ORAL BIOAVAILABILITY OF PROPRANOLOL

被引：31

作者：

WALLE, T ^{[1
]}

WALLE, UK ^{[1
]}

OLANOFF, LS ^{[1
]}

CONRADI, EC ^{[1
]}

机构：

[1] MED UNIV S CAROLINA,DEPT MED,CHARLESTON,SC 29425

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1986年 / 22卷 / 03期

关键词：

D O I：

10.1111/j.1365-2125.1986.tb02893.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：317 / 323

页数：7

共 28 条

[1] INHIBITION OF ANTIPYRINE METABOLISM BY BETA-ADRENOCEPTOR ANTAGONISTS [J].

BAX, NDS ;

LENNARD, MS ;

TUCKER, GT .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 12 (06) :779-784

[2] INTERINDIVIDUAL VARIATIONS IN DRUG DISPOSITION - CLINICAL IMPLICATIONS AND METHODS OF INVESTIGATION [J].

BREIMER, DD .

CLINICAL PHARMACOKINETICS, 1983, 8 (05) :371-377

[3]

EVANS GH, 1973, CLIN PHARMACOL THER, V14, P487

[4]

FAGAN TC, 1983, 2ND WORLD C CLIN PHA

[5] INDUCTION OF HEPATIC-MICROSOMAL PROPRANOLOL N-DESISOPROPYLASE ACTIVITY BY 3-METHYLCHOLANTHRENE AND SUDAN-III [J].

FUJITA, S ;

USUI, T ;

SUZUKI, M ;

HIRASAWA, M ;

MORI, Y ;

NAGANUMA, H ;

SUZUKI, T .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1982, 105 (03) :1233-1239

[6] INFLUENCE OF FIRST-PASS EFFECT ON AVAILABILITY OF DRUGS ON ORAL ADMINISTRATION [J].

GIBALDI, M ;

BOYES, RN ;

FELDMAN, S .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1971, 60 (09) :1338-&

[7]

KORNHAUSER DM, 1978, CLIN PHARMACOL THER, V23, P165

[8] PURIFICATION AND CHARACTERIZATION OF THE RAT-LIVER MICROSOMAL CYTOCHROME-P-450 INVOLVED IN THE 4-HYDROXYLATION OF DEBRISOQUINE, A PROTOTYPE FOR GENETIC-VARIATION IN OXIDATIVE DRUG-METABOLISM [J].

LARREY, D ;

DISTLERATH, LM ;

DANNAN, GA ;

WILKINSON, GR ;

GUENGERICH, FP .

BIOCHEMISTRY, 1984, 23 (12) :2787-2795

[9] THE RELATIONSHIP BETWEEN DEBRISOQUINE OXIDATION PHENOTYPE AND THE PHARMACOKINETICS AND PHARMACODYNAMICS OF PROPRANOLOL [J].

LENNARD, MS ;

JACKSON, PR ;

FREESTONE, S ;

TUCKER, GT ;

RAMSAY, LE ;

WOODS, HF .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 17 (06) :679-685

[10]

LO MW, 1982, J PHARMACOL EXP THER, V221, P512

← 1 2 3 →